Dick Bagley is a highly qualified expert, working in ZIOPHARM Oncology Inc main office of which is in 499. as a President/COO/CFO/Director of ZIOPHARM Oncology, Inc. from 2004. Dick has earned professional experience in more than six positions at different companies. Dick Bagley went to the Harvard Graduate School of Education and got education there from 1965 to 1967. Eliot, Maine is the city, where the professional was known to settle. The professional's e-mail and phone can be accessed through SoftwareOfficial on demand.
Name variants:
Richard Bagley
Last updated May 05, 2024
Contact Information
Last Update
Jul 4, 2022
Email
db**@ziopharm.com, di**@aol.com
Location
Eliot, ME
Company
ZIOPHARM Oncology Inc.
Workplace
President/COO/CFO/Director of ZIOPHARM Oncology, Inc.
Work History
President/COO/CFO/Director of ZIOPHARM Oncology, Inc.
Boston MA
Clinical stage small molecules and synthetic biology; responsible for Boston operations; in-licensed/purchased three product candiates; small molecule palifosfamide in Phase 3 front-line met...
Jul 2004 — Jul 2012
President and CEO
Antibody-based cancer immunotherapeutics; OvaRex(R) for ovarian cancer unsuccessful in two Phase 3 trials; moved company from Edmonton Canada to Boston area; public company on Toronto Stock ...
1998 — 2003
Chairman, President, CEO
Small molecules to treat cancer, inflammatory disease, muscle wasting; two products advanced to clinical evaluation with one now Millennium's Velcade(R); multiple partnerships
1994 — 1998
President, CEO
Immunotherapeutic company to treat allergies and autoimmune disease; raised over $140 million from IPO/secondary offerings; multiple partnerships
1990 — 1994
President E.R. Squibb U.S. and other positions
Over 1000 employees, sales in excess of half billion; included eventual billion dollar drug Capoten(R) (repositioned for heart failure) and prelaunch planning for Pravachol(R) and new ACE in...
1988 — 1989
President SmithKline Consumer; Vice President Product Management and other positions
Consumer Products with 450 employees and $150 million in sales predominantly in U.S., Canada, France, and Japan; switched Ecotrin(R) from Rx $40 million consumer product with television adve...
1968 — 1985
Education
1965 — 1967
1961 — 1965
Occupations
Executive
Chief Executive Officer
Chairperson
Chief Operating Officer
Financial Director
Director
Doctor
Oncologist
Corporate Executive
Chief Executive
General and Operations Manager
Financial Officer
Financial Manager
Operations Manager
Medical Practice Professional
Medical Practitioner
Skills
Biotechnology
Clinical Trials
Pharmaceutical Industry
Oncology
Clinical Development
Biopharmaceuticals
Regulatory Submissions
Drug Development
Clinical Research
Cancer
Drug Discovery
Cro
Lifesciences
Medical Writing
Cell
Start Ups
Commercialization
Fda
Technology Transfer
Vaccines
Immunology
Regulatory Affairs
Clinical Data Management
Life Sciences
Validation
Licensing
Patents
Corporate Development
Pharmaceutics
Healthcare
Competitive Intelligence
Sop
Venture Capital
Ctms
Medical Devices
Gcp
Ind
Medical Affairs
Gmp
Pharmacovigilance
Infectious Diseases
21 Cfr Part 11
Edc
Standard Operating Procedure